Northwestern University;The Governors of the University of Alberta
发明人:
Tsutomu Kume,Ordan Lehmann
申请号：
US16278438
公开号：
US20190270782A1
申请日:
2019.02.18
申请国别(地区):
US
年份:
2019
代理人:
摘要：
Disclosed are methods and pharmaceutical compositions for treating and inhibiting conical vascularization including conical vascularization associated with viral infection, chemical injury, autoimmune conditions, and post-corneal transplantation or in subjects having a PAX6 mutation associated with conical vascularization. The methods and pharmaceutical compositions are utilized in administering treatment that results in increased concentration of FOXC1 in a subject's cornea in order to treat or inhibit corneal vascularization.
